Kuehne+Nagel launches Hyderabad pharma logistics facility

Kuehne + Nagel has expanded its healthcare logistics network in India with the opening of a temperature-controlled airfreight cross-dock facility in Hyderabad. The company said the investment is aimed at supporting the movement of healthcare products and responding to demand for specialised logistics solutions for pharmaceutical and medical shipments.

The facility is located in Hyderabad, a centre for pharmaceutical manufacturing in India. The city accounts for over 40 per cent of the country’s active pharmaceutical ingredient and vaccine production. The company said the location allows closer access to manufacturing sites and customers, improving handling and distribution.

The 248 sqm site operates across multiple temperature ranges, including +2°C to +8°C and +15°C to +25°C. These zones are designed to maintain product integrity during handling and transit. The company stated that the facility complies with its HealthChain quality standard, which aligns with GxP requirements across healthcare supply chains.

With the addition of the Hyderabad site, Kuehne + Nagel now operates two HealthChain-certified facilities in India. The expansion follows the launch of its Cool Zone facility in Bengaluru in December 2025.

Anish Kumar Jha, Managing Director for Kuehne+Nagel India, Sri Lanka and the Maldives, said: “This investment strengthens our healthcare logistics network in India and brings us closer to customers operating in one of the country’s most important pharmaceutical hubs. By investing in specialised, HealthChain-certified infrastructure, we are supporting Indian healthcare companies as they grow and connect to global markets through compliant, temperature-controlled supply chains.”

Kuehne+Nagel operates more than 1,300 sites in close to 100 countries with a workforce of over 85,000 employees. The group provides air, sea, road and contract logistics services and supports around 400,000 customers through its global network.